不同介入法治疗123例肝癌的疗效分析  

The analysis of different interventional therapy in 123 liver cancer patients

作　　者：张志胜[1] 

机构地区：[1]江苏省姜堰市人民医院,225500

出　　处：《重庆医学》2011年第33期3382-3383,共2页Chongqing medicine

摘　　要：目的探讨不同介入法治疗123例肝癌的疗效。方法回顾性分析123例肝癌患者的临床资料,其中41例采取肝动脉栓塞化疗(TACE)治疗(A组),42例采取高能超声聚焦刀(HIFU)治疗(B组),40例采取TACE联合HIFU治疗(C组),比较3组患者介入治疗效果。结果 C组肿瘤完全反应率、血清甲胎蛋白(AFP)变化,以及介入治疗后1、3年存活率明显高于A、B组(P<0.05);A、B组间比较差异无统计学意义(P>0.05)。结论 TACE联合HIFU治疗肝癌,疗效显著,可提高患者短期生存率,是肝癌非手术治疗的理想方式。Objective To investigate the effects of different interventional therapy in 123 liver cancer patients. Methods 123 patients with bepatocellular carcinoma were retrospectively analyzed. 41 cases were treated with TACE（group A）,42 patients were treated with HIFU（group B） and 40 patients were treated with TACE combined with HIFU（group C）. Results Compared with group A and B, the complete tumor response rate, AFP level and 1,3-year survival rate were higher in group C（P〈0.05）. However,there was no statistical significant difference between group A and B. Conclusion TACE combined with HIFU can improve the short-term survival,is a ideal way to treat hepatocellar carcinoma.

关 键 词：肝肿瘤 介入治疗 手术切除 

分 类 号：R735.7[医药卫生—肿瘤]